INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $552,258 | +0.8% | 10,602 | +22.5% | 0.04% | +2.8% |
Q2 2023 | $548,098 | -5.4% | 8,656 | -19.1% | 0.04% | -12.2% |
Q1 2023 | $579,080 | +952.9% | 10,694 | +799.4% | 0.04% | +925.0% |
Q3 2022 | $55,000 | -90.9% | 1,189 | -89.7% | 0.00% | -91.8% |
Q4 2021 | $604,000 | +1625.7% | 11,554 | +730.6% | 0.05% | +1125.0% |
Q3 2020 | $35,000 | -64.3% | 1,391 | -89.4% | 0.00% | -60.0% |
Q3 2019 | $98,000 | +1300.0% | 13,174 | +1845.9% | 0.01% | +900.0% |
Q4 2018 | $7,000 | -93.0% | 677 | -85.3% | 0.00% | -85.7% |
Q3 2018 | $100,000 | +9900.0% | 4,609 | +5520.7% | 0.01% | – |
Q2 2018 | $1,000 | -99.2% | 82 | -98.6% | 0.00% | -100.0% |
Q1 2018 | $119,000 | +133.3% | 5,698 | +61.2% | 0.01% | +100.0% |
Q4 2017 | $51,000 | -62.2% | 3,534 | -59.0% | 0.01% | -61.5% |
Q3 2017 | $135,000 | +321.9% | 8,614 | +233.1% | 0.01% | +333.3% |
Q2 2017 | $32,000 | -44.8% | 2,586 | -33.1% | 0.00% | -50.0% |
Q4 2016 | $58,000 | +141.7% | 3,864 | +527.3% | 0.01% | +50.0% |
Q3 2015 | $24,000 | – | 616 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |